Third, treatment with STAT3 siRNA reduces VEGF secretion by GBM cells, suggesting that STAT3 could regulate astrocytoma invasive capability by affecting angiogenesis. This evidence concerns the gene STAT3 and astrocytoma (excluding glioblastoma).